Financial Year |
March 31 2023 |
Monetary Funds |
1,600,678,038.17 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
324,110,719.25 |
Accounts Receivable |
5,517,160,873.15 |
Advances to Suppliers |
481,690,173.32 |
Other Receivables |
1,359,530,065.29 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
6,468,229.70 |
Inventories |
449,671,746.34 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
43,658,160.66 |
Total Current Assets |
10,375,907,752.97 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
75,147,321.32 |
Investment Properties |
72,690,940.03 |
Fixed Assetes |
1,764,872,884.81 |
Under-construction Projects |
167,468,073.55 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
877,575,247.07 |
R&D expenses |
33,897.32 |
Goodwill |
234,004,966.36 |
Long-Term Deferred and Prepaid Expenses |
102,471,293.53 |
Deferred Income Tax Assets |
285,072,945.66 |
Other Non-Current Assets |
2,402,455,355.07 |
Sub-Total of Non-Current Assets |
6,124,759,385.40 |
Total Assets |
16,500,667,138.37 |
Short-Term Loans |
3,322,561,976.83 |
Trading Financial liabilities |
-- |
Notes Payable |
562,967,000.04 |
Accounts Payable |
2,809,059,226.26 |
Accounts Received In Advance |
1,675,933.00 |
Employee Compensation Payable |
102,613,068.54 |
Taxes Payable |
162,316,989.92 |
Interest Payable |
-- |
Dividend Payable |
34,081,179.34 |
Other payables |
1,147,425,916.75 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
640,324,644.75 |
Other Current Liabilities |
757,698,684.75 |
Sub-Total of Current Liabilities |
9,606,464,681.19 |
Long-term Loans |
2,331,459,365.01 |
Bonds Payable |
306,237,500.00 |
Long-Term Accounts Payable |
60,675,395.48 |
Special Payable |
-- |
Estimatied Liabilities |
1,697,229.09 |
Deferred Income Tax Liabilities |
82,522,358.45 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
3,163,241,863.94 |
Total Liabilities |
12,769,706,545.13 |
Paid-In Capital(Or Share Stock) |
483,883,566.00 |
Capital Surplus |
1,339,900,213.90 |
Surplus Reserve |
178,647,947.74 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
497,134,195.77 |
Minority Stockholder's Interest |
1,179,956,498.28 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,551,004,094.96 |
Owner's Equity(Stockholder's Equity) |
3,730,960,593.24 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
16,500,667,138.37 |